Loop Diagnostics

Revolutionizing sepsis detection for early intervention

Loop Diagnostics is a biotech company that develops a diagnostic tool for sepsis, using an in vitro cellular immunoassay to detect it within the first hour of bloodstream infection, SeptiLoop. Our goal is to reduce disease severity and mortality rates through timely and effective treatment.

SeptiLoop is a groundbreaking in vitro diagnostic lateral flow assay that takes a new approach to sepsis detection.

Unlike traditional methods that focus on pathogen identification, our approach measures the status and response of the immune system of the septic patient. SeptiLoop can diagnose bacteremia as early as one hour after infection and throughout all stages of sepsis, enabling healthcare professionals an early detection and timely treatment initiation.